CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-01 | Schlanger David J Executive Chairman | Exercise or conversion | +41,667 | $0.91 | $38K | 124,215 |
| 2022-09-01 | Schlanger David J Executive Chairman | Sale | −41,667 | $39.01 | $1.6M | 82,548 |
| 2022-09-01 | Schlanger David J Executive Chairman | Exercise or conversion · Option (Right to Buy) | −41,667 | 1,567,013 | ||
| 2022-09-01 | Payson Norman Director | Sale | −6,418 | $38.78 | $249K | 378,522 |
| 2022-09-01 | Payson Norman Director | Sale | −200 | $39.55 | $8K | 378,322 |
| 2022-09-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −7,856 | $40.21 | $316K | 79,291 |
| 2022-08-31 | Payson Norman Director | Sale | −6,618 | $40.33 | $267K | 384,940 |
| 2022-08-30 | Dean Lloyd H Director | Grant or award · Common Stock | +44,000 | 44,000 | ||
| 2022-08-26 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −158 | $43.85 | $7K | 87,147 |
| 2022-08-26 | Sturmer Michael E PRESIDENT | Shares withheld for taxes | −6,407 | $43.85 | $281K | 216,757 |
| 2022-08-18 | Payson Norman Director | Sale | −2,512 | $43.77 | $110K | 395,664 |
| 2022-08-18 | Payson Norman Director | Sale | −4,106 | $44.76 | $184K | 391,558 |
| 2022-08-17 | Payson Norman Director | Sale | −6,518 | $43.67 | $285K | 398,276 |
| 2022-08-17 | Payson Norman Director | Sale | −100 | $44.26 | $4K | 398,176 |
| 2022-08-12 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +16,000 | $3.95 | $63K | 340,916 |
| 2022-08-12 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −15,600 | $44.90 | $700K | 325,316 |
| 2022-08-12 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −400 | $45.25 | $18K | 324,916 |
| 2022-08-12 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −3,900 | $44.90 | $175K | 142,226 |
| 2022-08-12 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −100 | $45.25 | $5K | 142,126 |
| 2022-08-12 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Common Stock | −16,000 | 1,595,556 |
Page 45 of 77 · 1,524 trades